Business
First German Hospital Pilots Steriwave
Ondine Biomedical Inc. has announced a significant research collaboration with LMU University Hospital Munich to pilot its Steriwave photodisinfection technology in Germany, marking a key step for international market expansion. This partnership leverages the expertise of LMU's LIFE Center and builds on previous clinical evidence, including a pilot study that showed a substantial reduction in post-operative antibiotic prescriptions from 22.5% to 5% in sinonasal surgery patients. The company aims to combat antibiotic resistance and improve patient outcomes with this non-antibiotic infection prevention strategy. Disclaimer*
About this update from Ondine Biomedical, Inc.
[{"type":"text","content":"\n\n22 December 2025\nONDINE BIOMEDICAL INC.\n(\"Ondine Biomedical\", \"Ondine\" or the \"Company\")\n \nFirst German Hospital Pilots Steriwave\n \nOndine Biomedical Partners with LMU University Hospital Munich\n to Trial Steriwave in ENT Patients\n \n \nOndine Biomedical Inc. (AIM: OBI) is pleased to announce a significant research collaboration with LMU University Hospital Munich, one of Europe's most esteemed and highly ranked medical institutions. This partnership marks a pivotal step in introducing Ondine's Steriwave® photodisinfection technology to Germany, the European Union, and other major international markets, underscoring the growing importance of innovative infection prevention solutions in global healthcare.\n \nThe collaborative research initiative will be led by Professor Dr. Ronald Sroka, Head of the LIFE Center and Laser Research Laboratory at LMU University Hospital Munich, along with PD Dr. Veronika Volgger, Clinical Scientist at LIFE Center and Department of ENT at LMU University Hospital Munich. Renowned for its excellence in biophotonics and photodynamic therapy (PDT), the LIFE Center brings unparalleled expertise to this project, further strengthening the scientific foundation for Steriwave's clinical evaluation in ENT patients.\n \nThis initiative is bolstered by external clinical evidence, including a pilot study presented at the American Rhinologic Society's 66th Annual Meeting in 2020 by Prof. Claire Hopkins, consultant ENT surgeon at Guy's & St Thomas Hospital and London Bridge Hospital, and her team. Their findings demonstrated that routine pre-operative nasal photodisinfection significantly reduced the need for post-operative antibiotics in sinonasal surgery patients, with prescription rates dropping from 22.5% to 5% (P=0.02), highlighting the technology's potential to combat healthcare-associated infections and antimicrobial resistance.\n \nProfessor Dr. Ronald Sroka commented:\n\"Innovative solutions are more vital than ever in the fight against antibiotic resistance. Our team at LMU is deeply committed to advancing photodynamic approaches that address the growing threat of antimicrobial resistance. Ondine's Steriwave represents a promising, non-antibiotic strategy to reduce multidrug-resistant infections, and we are delighted to bring our clinical expe...